Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma
葡萄膜黑色素瘤 BAP1 转移抑制基因的功能分析
基本信息
- 批准号:8585837
- 负责人:
- 金额:$ 34.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-16 至 2016-11-30
- 项目状态:已结题
- 来源:
- 关键词:3p21AblationAdhesionsAffinity ChromatographyAnimal ModelAnimalsAntibodiesBAP1 geneBRCA1 geneBindingBiologicalBiologyCandidate Disease GeneCell Culture TechniquesCell Differentiation processCell LineCellsChIP-seqChromatinChromosomesComplexDevelopmentEarly DiagnosisEarly treatmentEnzymesEpigenetic ProcessEpitopesEye NeoplasmsGene Expression ProfileGene Expression RegulationGene TargetingGenesGeneticHistone CodeHumanHydrolysisImageIn VitroLaboratoriesLifeLiver neoplasmsLuciferasesMaintenanceMapsMediatingMelanoma CellMessenger RNAMetastasis SuppressionMetastasis Suppressor GenesMetastatic toModelingMorbidity - disease rateMorphologyMultiprotein ComplexesMusMutateNeoplasm MetastasisOrganPathogenesisPathway interactionsPatientsPhenotypePlayPolycombPreventiveProcessProteinsProteomicsPublic HealthRecombinant ProteinsReportingRiskRoleSpecimenTechnologyThe Wistar InstituteTherapeuticTimeTropismTumor Suppressor GenesTumor Suppressor ProteinsTumor-DerivedUbiquitinUveal MelanomaVariantWorkXenograft procedurebasecomparativedomain mappinggenome wide association studyin vivoin vivo Modelmalignant neoplasm of eyemelanomamigrationmortalitymutantnew therapeutic targetoutcome forecastpromoterprotein complexreconstitutionresearch studytumortumor growth
项目摘要
DESCRIPTION (provided by applicant): Uveal Melanoma (UM) is the most common form of primary eye cancer and is associated with very poor prognosis and morbidity. UM often metastasizes, primarily to the liver and metastatic tumors are uniformly fatal. Gene profiling of tumors has allowed subdividing UMs into Low Metastatic risk (Class 1) and High Metastatic risk (Class 2) variants however, until recently, the genetic basis for this metastatic propensity was unclear. In late November of 2010, Harbour et al. reported that the tumor suppressor gene, BAP1 is mutated in 84% of Class 1 metastatic tumors. BAP1 directly controls the metastatic phenotype of UM as shown by ablation of wild type BAP1 expression. Nothing is known of the mechanism by which BAP1 controls the metastatic phenotype in UM. BAP1 was originally discovered in 1998 by the Rauscher Laboratory We showed that it possessed tumor suppressor activity and catalyzes ubiquitin hydrolysis. Recent work has shown that BAP1 participates in gene regulation by participating in multi-protein complexes which control cell differentiation and development. Thus, BAP1 likely controls the metastatic phenotype via epigenetic mediated gene regulation. In this proposal we will provide a mechanistic basis for the control of metastasis in UM by connecting the biological and transcriptional roles of BAP1 in in vitro and animal models of UM by performing the following specific aims: 1) Define the role of BAP1 in metastasis of uveal melanoma using cell culture and animal models. 2) Identify the spectrum of genes influenced by BAP1 during establishment and maintenance of the metastatic phenotype. 3) Identify Promoters which are directly targeted in chromatin by the BAP1-containing polycomb complex. 4) Define the composition and functions of the BAP1 multiprotein complex in UM cells and its role in gene regulation, ubiquitin hydrolysis and biologic functions of BAP1. These experiments will provide a mechanistic basis for metastasis suppression by BAP1 and validate it as a key target for controlling the pathogenesis of Uveal Melanoma.
描述(申请人提供):葡萄膜黑色素瘤(UM)是最常见的原发眼癌,预后和发病率都很差。UM通常转移,主要转移到肝脏,转移的肿瘤通常是致命的。肿瘤的基因图谱使肿瘤可以细分为低转移风险(1类)和高转移风险(2类)变体,然而,直到最近,这种转移倾向的遗传基础还不清楚。2010年11月下旬,港湾等人。报道称,肿瘤抑制基因BAP1在84%的1类转移瘤中发生突变。BAP1直接控制UM的转移表型,如野生型BAP1表达的消融所示。BAP1控制UM转移表型的机制尚不清楚。BAP1最早是由Rauscher实验室于1998年发现的,我们证明它具有肿瘤抑制活性,并催化泛素水解。最近的研究表明,BAP1通过参与控制细胞分化和发育的多蛋白复合体来参与基因调控。因此,BAP1可能通过表观遗传介导的基因调控来控制转移表型。在这项研究中,我们将通过将BAP1在体外和UM动物模型中的生物学和转录作用联系起来,从而为UM的转移控制提供机制基础,具体目的如下:1)通过细胞培养和动物模型确定BAP1在葡萄膜黑色素瘤转移中的作用。2)确定在建立和维持转移表型过程中受BAP1影响的基因谱。3)确定含有BAP1的多梳复合体直接靶向染色质的启动子。4)明确UM细胞中BAP1多蛋白复合体的组成和功能,及其在基因调控、泛素水解和BAP1生物学功能中的作用。这些实验将为BAP1抑制肿瘤转移提供机制基础,并验证其作为控制葡萄膜黑色素瘤发病机制的关键靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANK JOSEPH RAUSCHER III其他文献
FRANK JOSEPH RAUSCHER III的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANK JOSEPH RAUSCHER III', 18)}}的其他基金
Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXL
人多梳复合物 BAP1-ASXL 引起恶性间皮瘤的发病机制
- 批准号:
8630368 - 财政年份:2014
- 资助金额:
$ 34.55万 - 项目类别:
Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXL
人多梳复合物 BAP1-ASXL 引起恶性间皮瘤的发病机制
- 批准号:
9191343 - 财政年份:2014
- 资助金额:
$ 34.55万 - 项目类别:
Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXL
人多梳复合物 BAP1-ASXL 引起恶性间皮瘤的发病机制
- 批准号:
8788699 - 财政年份:2014
- 资助金额:
$ 34.55万 - 项目类别:
Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma
葡萄膜黑色素瘤 BAP1 转移抑制基因的功能分析
- 批准号:
8986161 - 财政年份:2011
- 资助金额:
$ 34.55万 - 项目类别:
Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma
葡萄膜黑色素瘤 BAP1 转移抑制基因的功能分析
- 批准号:
8411933 - 财政年份:2011
- 资助金额:
$ 34.55万 - 项目类别:
Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma
葡萄膜黑色素瘤 BAP1 转移抑制基因的功能分析
- 批准号:
8222518 - 财政年份:2011
- 资助金额:
$ 34.55万 - 项目类别:
Role of Gene Silencing in the DNA Damage Response
基因沉默在 DNA 损伤反应中的作用
- 批准号:
8241122 - 财政年份:2009
- 资助金额:
$ 34.55万 - 项目类别:
Role of Gene Silencing in the DNA Damage Response
基因沉默在 DNA 损伤反应中的作用
- 批准号:
8035996 - 财政年份:2009
- 资助金额:
$ 34.55万 - 项目类别:
Role of Gene Silencing in the DNA Damage Response
基因沉默在 DNA 损伤反应中的作用
- 批准号:
8461077 - 财政年份:2009
- 资助金额:
$ 34.55万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 34.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 34.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 34.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 34.55万 - 项目类别:
Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 34.55万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 34.55万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 34.55万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 34.55万 - 项目类别:
Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
- 批准号:
515081333 - 财政年份:2023
- 资助金额:
$ 34.55万 - 项目类别:
Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 34.55万 - 项目类别:
Standard Grant














{{item.name}}会员




